HomeINNPF • OTCMKTS
add
Innocan Pharma Corp
Previous close
$0.15
Year range
$0.091 - $0.30
Market cap
60.35M CAD
Avg Volume
50.00
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 8.62M | 111.22% |
Operating expense | 7.43M | 52.51% |
Net income | -290.00K | 85.69% |
Net profit margin | -3.36 | 93.23% |
Earnings per share | — | — |
EBITDA | 361.00K | 130.16% |
Effective tax rate | 59.54% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.06M | 25.67% |
Total assets | 9.60M | 39.75% |
Total liabilities | 2.65M | 12.13% |
Total equity | 6.94M | — |
Shares outstanding | 281.64M | — |
Price to book | 7.32 | — |
Return on assets | 9.61% | — |
Return on capital | 13.55% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -290.00K | 85.69% |
Cash from operations | -1.00M | -39.69% |
Cash from investing | -6.00K | 81.25% |
Cash from financing | 859.00K | -40.68% |
Net change in cash | -132.00K | -120.28% |
Free cash flow | -811.25K | -183.52% |
About
Founded
2018
Website
Employees
8
